Tella

Dendritic cell vaccine for WT1 peptide

placeTokyo, Tokyo, Japan calendar_todayFounded 2004 groups30 employees language tella.jp

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon